ATYR
aTyr Pharma·NASDAQ
--
--(--)
--
--(--)
ATYR fundamentals
aTyr Pharma (ATYR) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.22 (YoY +4.35%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.22
+4.35%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.EPS
Actual | 0.25 | -0.69 | -0.68 | -0.47 | -0.51 | -0.64 | -0.42 | -0.31 | -0.44 | -0.44 | -0.46 | -0.26 | -0.29 | -0.22 | -0.2 | -0.25 | -0.23 | -0.23 | -0.23 | -0.18 | -0.17 | -0.22 | |||||||||
Forecast | -0.18 | -0.73 | -0.7433 | -0.8233 | -0.3175 | -0.508 | -0.5929 | -0.2833 | -0.316 | -0.382 | -0.4633 | -0.48 | -0.35 | -0.2786 | -0.226 | -0.238 | -0.25 | -0.2533 | -0.22 | -0.2256 | -0.191 | -0.1845 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +238.89% | +5.48% | +8.52% | +42.91% | -60.63% | -25.98% | +29.16% | -9.42% | -39.24% | -15.18% | +0.71% | +45.83% | +17.14% | +21.03% | +11.50% | -5.04% | +8.00% | +9.20% | -4.55% | +20.21% | +10.99% | -19.24% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.06M | 189.00K | 148.00K | 2.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.39M | 0 | 0 | 353.00K | 0 | 235.00K | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.40M | 399.10K | 103.33K | 126.00K | 3.98M | 621.80K | 266.67K | 2.52M | 200.00K | 2.50M | 400.00K | 357.14K | 2.36M | 611.67K | 1.50M | 3.42M | 36.67K | 60.00K | 21.67K | 15.56K | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +83.33% | -52.64% | +43.23% | +1529.37% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | +2808.08% | -100.00% | -100.00% | -76.47% | -100.00% | +540.90% | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is aTyr Pharma's gross profit margin?What were the key takeaways from aTyr Pharma's earnings call?What is the market's earnings forecast for aTyr Pharma next quarter?What were the key takeaways from aTyr Pharma’s earnings call?What does aTyr Pharma do and what are its main business segments?What guidance did aTyr Pharma's management provide for the next earnings period?What is the revenue and EPS growth rate for aTyr Pharma year over year?What factors drove the changes in aTyr Pharma's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
